Iran vs Philippines: New cases tested for RR-/MDR-TB
Iran
80.0%
in 2024
Philippines
79.0%
in 2024
Iran rank
127th
Philippines rank
130th
New cases tested for RR-/MDR-TB over time
- Iran
- Philippines
How they compare
Iran currently reports 80.0% against 79.0% in Philippines, a difference of 1.0%.
The two have swapped places 4 times across 19 shared years of data; in 2005 it was Iran ahead.
Iran ranks 127th and Philippines ranks 130th of 192 countries.
Across the 3 decades both report, Iran averaged higher in 2 and Philippines in 1.
Head to head by decade
| Decade | Iran | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.5% | 0.1% | 6.4% | Iran |
| 2010s | 28.5% | 14.2% | 14.3% | Iran |
| 2020s | 55.0% | 86.0% | 31.0% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Iran or Philippines?
- Iran, at 80.0% against 79.0% in Philippines as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Iran and Philippines?
- 1.0%, with Iran ahead.
- How many years of comparable data are there for Iran and Philippines?
- 19 years are reported by both, from 2005 to 2024.
- How do Iran and Philippines rank globally for new cases tested for rr-/mdr-tb?
- Iran ranks 127th and Philippines ranks 130th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.